Current Treatment Landscape of Advanced Papillary Renal Cancer

被引:13
作者
Shuch, Brian [1 ]
Hahn, Andrew W. [2 ]
Agarwal, Neeraj [2 ,3 ]
机构
[1] Yale Sch Med, New Haven, CT 06510 USA
[2] Univ Utah, Sch Med, Salt Lake City, UT USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
关键词
CELL CARCINOMA; PHASE-II; SUNITINIB;
D O I
10.1200/JCO.2017.74.3328
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2981 / +
页数:4
相关论文
共 50 条
  • [31] Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives
    Timsit, Marc-Olivier
    Albiges, Laurence
    Mejean, Arnaud
    Escudier, Bernard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (12) : 1559 - 1569
  • [32] Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer
    Choueiri, Toni K.
    Plimack, Elizabeth
    Arkenau, Hendrik-Tobias
    Jonasch, Eric
    Heng, Daniel Y. C.
    Powles, Thomas
    Frigault, Melanie M.
    Clark, Edwin A.
    Handzel, Amir A.
    Gardner, Humphrey
    Morgan, Shethah
    Albiges, Laurence
    Pal, Sumanta Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) : 2893 - +
  • [33] Sorafenib for the treatment of renal cancer
    Strumberg, Dirk
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (03) : 407 - 419
  • [34] Pazopanib for the treatment of renal cancer
    Rini, Brian
    Al-Marrawi, Mhd Yaser
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (07) : 1171 - 1189
  • [35] Current State of Systemic Therapies for Advanced Renal Cell Carcinoma
    Gulati, Shuchi
    Vaishampayan, Ulka
    CURRENT ONCOLOGY REPORTS, 2020, 22 (03)
  • [36] The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma
    Amin, Asim
    Hammers, Hans
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [37] Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review
    Lalani, Aly-Khan A.
    Heng, Daniel Y. C.
    Basappa, Naveen S.
    Wood, Lori
    Iqbal, Nayyer
    McLeod, Deanna
    Soulieres, Denis
    Kollmannsberger, Christian
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [38] Papillary Renal Cell Carcinoma: Current Evidence and Future Directions
    Jang, Albert
    Hobeika, Charbel S.
    Gupta, Shilpa
    KIDNEY CANCER, 2024, 8 (01) : 61 - 79
  • [39] The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions
    Salgia, Nicholas J.
    Dara, Yash
    Bergerot, Paulo
    Salgia, Meghan
    Pal, Sumanta K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (05)
  • [40] Papillary Renal Cell Carcinoma: Current Progress and Future Directions
    Twardowski, Przemyslaw W.
    Mack, Philip C.
    Lara, Primo N., Jr.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (02) : 74 - 79